Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?

被引:5
|
作者
Gaddas, M. [1 ]
Chaouache, N. [1 ]
Ajina, M. [2 ]
Tabka, Z. [1 ]
Ajina, M. Zaouali [1 ]
机构
[1] Fac Med Ibn el Jazzar, Lab Physiol & Explorat Fonct, Ave Mohamed Karoui, Sousse 4000, Tunisia
[2] CHU Farhat Hached, Unite Med Reprod, Ave Ibn el Jazzar, Sousse 4000, Tunisia
关键词
Hyperandrogenism; IVF; Polycystic ovarian; syndrome; SYNDROME PCOS; ANDROGEN RECEPTORS; INSULIN-RESISTANCE; DOWN-REGULATION; WOMEN; TESTOSTERONE; CYCLES; CELL; STIMULATION; APOPTOSIS;
D O I
10.1016/j.jgyn.2016.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV). Materials and methods. It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups. Results. SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response. Conclusion. Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [1] Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization
    Foong, Shu C.
    Abbott, David H.
    Zschunke, Michael A.
    Lesnick, Timothy G.
    Phy, Jennifer L.
    Dumesic, Daniel A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06): : 2327 - 2333
  • [2] Is in vitro fertilization the answer in polycystic ovary syndrome?
    Gupta, Sajal
    Sinha, Annika
    FERTILITY AND STERILITY, 2021, 115 (02) : 330 - 331
  • [3] Hyperandrogenic anovulation (the polycystic ovary syndrome) - back to the ovary?
    Ben-Shlomo, I
    Homburg, R
    Shalev, E
    HUMAN REPRODUCTION UPDATE, 1998, 4 (03) : 296 - 300
  • [4] Success rate of in vitro fertilization embryo transfer in obese patients with polycystic ovary syndrome
    Ailun, Gaowa
    Chen, Xiujuan
    Zhao, Xia
    Dalai, Tuya
    Sun, Hailong
    Zhang, Yanbing
    Du, Chen
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S390 - S391
  • [5] In vitro fertilization in the polycystic ovary syndrome patient: An update
    Lin, Kathleen
    Coutifaris, Christos
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01): : 268 - 276
  • [6] Polycystic ovary syndrome: Pathophysiology and outcome with in vitro fertilization
    Buyalos, RP
    Lee, CT
    FERTILITY AND STERILITY, 1996, 65 (01) : 1 - 10
  • [7] Hyperandrogenic Polycystic Ovary Syndrome (PCOS) Patients Have Reduced Pregnancy Rates Compared to Non-Hyperandrogenic PCOS Patients Following In Vitro Fertilization (IVF)
    Batcheller, April E.
    Rodriguez-Peterson, Kelci A.
    Martinez, Alan M.
    Thomas, Michael A.
    DiPaola, Krystene B.
    Sroga, Julie E.
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 177A - 177A
  • [8] Impact of Polycystic Ovary Syndrome Hyperandrogenic Phenotypes A and Non-Hyperandrogenic D on Pregnancy Outcomes After in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI)
    Khamaiseh, Khaldoun
    Bdeir, Roba
    Abukbeer, Mohammad Mahmoud
    Khamaiseh, Rami
    Nassar, Ali
    Jnr, Dina Nasser Al-Sawadha
    Mraikhat, Rasha Rakan Al
    Khraisat, Marah Jamal
    Alawneh, Rana Radi
    Al-Mansour, Omar
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 561 - 569
  • [9] SEXUAL DESIRE IN HYPERANDROGENIC WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Rellini, A. H.
    Stratton, N.
    Martini, E.
    Terreno, E.
    Santamaria, V
    Nappi, R. E.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 154 - 154
  • [10] A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
    Xue, Ping
    Wang, Zhiqiang
    Fu, Xiaomin
    Vvang, Junjiang
    Punchhi, Gopika
    Wolfe, Andrew
    Wu, Sheng
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (140):